BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22498738)

  • 1. PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.
    Federzoni EA; Valk PJ; Torbett BE; Haferlach T; Löwenberg B; Fey MF; Tschan MP
    Blood; 2012 May; 119(21):4963-70. PubMed ID: 22498738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.
    Humbert M; Federzoni EA; Britschgi A; Schläfli AM; Valk PJ; Kaufmann T; Haferlach T; Behre G; Simon HU; Torbett BE; Fey MF; Tschan MP
    J Leukoc Biol; 2014 Jan; 95(1):83-93. PubMed ID: 24038216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
    Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
    Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the autophagy-associated gene MAP1S via PU.1 supports APL differentiation.
    Haimovici A; Brigger D; Torbett BE; Fey MF; Tschan MP
    Leuk Res; 2014 Sep; 38(9):1041-7. PubMed ID: 25043887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the hematopoietic cell kinase (HCK) by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Zou D; Yang X; Tan Y; Wang P; Zhu X; Yang W; Jia X; Zhang J; Wang K
    Leuk Res; 2012 Feb; 36(2):219-23. PubMed ID: 21993313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells.
    Misra S; Selvam AK; Wallenberg M; Ambati A; Matolcsy A; Magalhaes I; Lauter G; Björnstedt M
    Oncotarget; 2016 Nov; 7(46):74686-74700. PubMed ID: 27732960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
    Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 controls the expression of long noncoding RNA HOTAIRM1 during granulocytic differentiation.
    Wei S; Zhao M; Wang X; Li Y; Wang K
    J Hematol Oncol; 2016 May; 9(1):44. PubMed ID: 27146823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
    Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
    Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies.
    Ablain J; Leiva M; Peres L; Fonsart J; Anthony E; de Thé H
    J Exp Med; 2013 Apr; 210(4):647-53. PubMed ID: 23509325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of low PU.1 expression in patients with acute promyelocytic leukemia.
    Zhu X; Zhang H; Qian M; Zhao X; Yang W; Wang P; Zhang J; Wang K
    J Hematol Oncol; 2012 May; 5():22. PubMed ID: 22569057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity.
    Noguera NI; Piredda ML; Taulli R; Catalano G; Angelini G; Gaur G; Nervi C; Voso MT; Lunardi A; Pandolfi PP; Lo-Coco F
    Oncotarget; 2016 Oct; 7(41):66386-66397. PubMed ID: 27626703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
    Orfali N; O'Donovan TR; Cahill MR; Benjamin D; Nanus DM; McKenna SL; Gudas LJ; Mongan NP
    Eur J Haematol; 2020 Mar; 104(3):236-250. PubMed ID: 31811682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
    Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
    Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells.
    Song G; Shi L; Guo Y; Yu L; Wang L; Zhang X; Li L; Han Y; Ren X; Guo Q; Bi K; Jiang G
    Oncotarget; 2016 Jan; 7(3):3144-57. PubMed ID: 26673819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.
    Brugnoli F; Lambertini E; Varin-Blank N; Piva R; Marchisio M; Grassilli S; Miscia S; Capitani S; Bertagnolo V
    Exp Cell Res; 2010 Jan; 316(1):38-47. PubMed ID: 19747912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.
    Wang K; Wang P; Shi J; Zhu X; He M; Jia X; Yang X; Qiu F; Jin W; Qian M; Fang H; Mi J; Yang X; Xiao H; Minden M; Du Y; Chen Z; Zhang J
    Cancer Cell; 2010 Feb; 17(2):186-97. PubMed ID: 20159610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WIPI-dependent autophagy during neutrophil differentiation of NB4 acute promyelocytic leukemia cells.
    Brigger D; Proikas-Cezanne T; Tschan MP
    Cell Death Dis; 2014 Jul; 5(7):e1315. PubMed ID: 24991767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [JMJD3 Exerts Oncorepressor Activity in Acute Promyelocytic Leukemia by Promoting PU.1 Expression].
    -Xi Wang M; -He Yu S; Xiao M; Chen J
    Mol Biol (Mosk); 2023; 57(4):665-667. PubMed ID: 37528785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.